|
|
|||||
| Department of Clinical Biochemistry | |
| School of Clinical Medicine > Department of Clinical Biochemistry > Diabetes, Obesity & Insulin Action |
| Professor Ken Siddle Professor of Molecular Endocrinology
Contact: Tel: 01223 336789 (office), 01223 336793 (lab) Research Interests Our research aims to achieve a better understanding, at the molecular level, of the mechanism of insulin action, the basis of specificity in the effects of insulin and insulin-like growth factors, and the causes of insulin resistance and non-insulin dependent diabetes. Our interests extend from ligand-receptor interactions, through the biochemistry and cell biology of signalling pathways, to biological responses with particular emphasis on adipose tissue. For a list of my principal publications click here My laboratory interacts closely with those of my colleagues Steve O'Rahilly, Jazz Sethi and Paul Luzio, with whom I have a number of joint projects. We have links with many centres in the UK, Europe, America and Australia, for exchange of reagents and ideas. We work mostly on cultured cell lines, and occasionally on animal or human tissues. We have always made heavy use of antibodies, both polyclonal and monoclonal, and still like to produce our own reagents wherever possible. We therefore have particular expertise in this area, including use of peptides or fusion proteins as immunogens, purification and assessment of antibodies, and applications in immunoprecipitation, immunoblotting and immunoassay. We have adopted a broad range of analytical and molecular biological techniques, including both proteomic and microarray approaches to expression profiling. We also have substantial experience in a variety of metabolic assays (glucose uptake, glycogen synthesis, lipolysis) and signalling pathways and in subcellular fractionation and protein purification. The Department is well equipped for all these techniques, and provides a challenging research environment in a clinical setting and in close proximity to many laboratories of international standing. Current projects includeReceptor structure and ligand binding
FundingWellcome Trust Group members
|